1,406 results on '"Jung, Sung Hoon"'
Search Results
2. Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
3. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model.
4. The Global–Regional Interplay of Korean Foreign Direct Investment in the European Union
5. Ultrahigh peroxidase-like catalytic performance of Cu–N4 and Cu–N4S active sites-containing reduced graphene oxide for sensitive electrochemical biosensing
6. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
7. Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma.
8. Contributions of age, gender, body mass index, and normalized arch height to hallux valgus: a decision tree approach
9. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
10. Exploring cellular immunotherapy platforms in multiple myeloma
11. Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma
12. Graphitic carbon nitride metal-free photocatalyst for the simultaneous removal of emerging pharmaceutical pollutants in wastewater
13. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia
14. Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)
15. Comparison of 2 L Polyethylene Glycol Plus Ascorbic Acid and 4 L Polyethylene Glycol in Elderly Patients Aged 60–79: A Prospective Randomized Study
16. Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: Results of the multicenter KMMWP2201 study
17. Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study
18. Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma
19. Enhanced photocatalytic activity in water splitting for hydrogen generation by using TiO2 coated carbon fiber with high reusability
20. Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms
21. Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party
22. Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline
23. Prediction model of subacromial pain syndrome in assembly workers using shoulder range of motion and muscle strength based on support vector machine.
24. Risk Factors for Impaired Cellular or Humoral Immunity after Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals.
25. Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study
26. Synthesis of zeolitic material from basalt rock and its adsorption properties for carbon dioxide.
27. Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
28. Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T Cell Lymphomas
29. Evaluation of the R2‐ISS in real‐world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)
30. Enhanced photodegradation of toxic volatile organic pollutants using Ni-doped graphitic carbon nitride under natural solar light
31. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model
32. Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
33. Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
34. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma
35. Which pelvic floor muscle functions are associated with improved subjective and objective symptoms after 8 weeks of surface electrical stimulation in women with stress urinary incontinence?
36. Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment
37. Enhanced solar‐light driven CO2 conversion using Pt‐doped graphitic carbon nitride photocatalyst
38. A Multi-Layer Perceptron Neural Network for Predicting the Diagnosis of Osteoporosis in Women Using Physical Activity Factors
39. Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma
40. Bone Marrow Cellularity at Diagnosis Predicts Outcomes of Patients with Myelodysplastic Syndrome with Allogeneic Hematopoietic Stem Cell Transplantation
41. Anti-BCMA Dual Epitope-Binding CAR-Marrow Infiltrating Lymphocytes (MILs) Could Offer a Potent Innovative Immunotherapeutic Tool Against Multiple Myeloma
42. Novel π-Extended Indolocarbazole-Based Deep-Blue Fluorescent Emitter with Remarkably Narrow Bandwidth for Solution-Processed Organic Light-Emitting Diodes
43. Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
44. Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)
45. Outcome of multiple myeloma patients with Hepatitis surface antigen:Korean Multiple myeloma working party 2103 study
46. Reaction Between High Mn-High Al Steel and CaO-SiO2Al2O3([pct Al]0≥((pct MgO)0≤-Type Molten Mold Flux: Retardation of 2Al2O3([pct Al]0≥((pct MgO)0≤ Accumulation at High Al Content 2Al2O3([pct Al]0≥((pct MgO)0≤2Al2O3([pct Al]0≥((pct MgO)0≤ 5) in Steel and Low MgO Content 2Al2O3([pct Al]0≥((pct MgO)0≤2Al2O3([pct Al]0≥((pct MgO)0≤ 1.8) in Flux
47. A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy
48. Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
49. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population
50. Pelvic Floor Muscle Parameters Affect Sexual Function After 8 Weeks of Transcutaneous Electrical Stimulation in Women with Stress Urinary Incontinence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.